STOCK TITAN
  1. Home
  2. Sec-filings
  3. THAR
  4. [EFFECT] Tharimmune, Inc. SEC Filing

[EFFECT] Tharimmune, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 16, 2026 4:30 P.M.
Form: S-3
CIK: 0001861657
Company Name: Tharimmune, Inc.
File Number: 333-292648

Source: View Original Filing on SEC EDGAR

Stock THAR logo
Tharimmune Inc

NASDAQ:THAR

THAR Rankings

#4906 Ranked by Market Cap
N/A Ranked by Dividends

THAR Latest News

Jan 22, 2026
Tharimmune, Inc. Announces Closing of $55 Million Underwritten Registered Direct Offering
Jan 20, 2026
Tharimmune, Inc. Announces Pricing of $55 Million Underwritten Registered Offering
Dec 18, 2025
Tharimmune, Inc. Statement on DTCC's Initiative to Tokenize U.S. Treasury Securities on the Canton Network
Dec 12, 2025
Tharimmune, Inc. Appoints Jacob Asbury as Chief Financial Officer to Advance Canton Coin Treasury Strategy
Nov 13, 2025
Tharimmune Receives Positive FDA Feedback for TH104 Prophylaxis Program Against Respiratory Depression from Fentanyl and Ultrapotent Opioids

THAR Latest SEC Filings

Jan 22, 2026
[8-K] Tharimmune, Inc. Reports Material Event
Jan 21, 2026
[SCHEDULE 13G/A] Tharimmune, Inc. Amended Passive Investment Disclosure
Jan 20, 2026
[8-K] Tharimmune, Inc. Reports Material Event
Jan 20, 2026
[424B5] Tharimmune, Inc. Prospectus Supplement (Debt Securities)
Jan 16, 2026
[DEF 14A] Tharimmune, Inc. Definitive Proxy Statement

THAR Stock Data

118.98M
32.47M
17.13%
1.5%
12.08%
Biotechnology
Pharmaceutical Preparations
Link
United States
BRIDGEWATER